Yiqun Shellman
Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 33 | 2021 | 709 | 6.810 |
Why?
| Skin Neoplasms | 14 | 2021 | 841 | 3.000 |
Why?
| Sulfonamides | 7 | 2020 | 455 | 2.450 |
Why?
| Neoplastic Stem Cells | 5 | 2021 | 340 | 2.300 |
Why?
| Nitrophenols | 5 | 2017 | 35 | 2.000 |
Why?
| Apoptosis | 14 | 2018 | 2532 | 1.990 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 8 | 2021 | 232 | 1.950 |
Why?
| Biphenyl Compounds | 5 | 2017 | 59 | 1.940 |
Why?
| Myeloid Cell Leukemia Sequence 1 Protein | 3 | 2020 | 22 | 1.460 |
Why?
| Antineoplastic Agents | 6 | 2021 | 1990 | 1.440 |
Why?
| Melanocytes | 8 | 2020 | 68 | 1.210 |
Why?
| Cell Line, Tumor | 23 | 2023 | 2904 | 1.080 |
Why?
| MicroRNAs | 4 | 2020 | 661 | 1.070 |
Why?
| Tankyrases | 1 | 2023 | 14 | 0.950 |
Why?
| Cell Culture Techniques | 3 | 2021 | 354 | 0.910 |
Why?
| GTP Phosphohydrolases | 2 | 2018 | 69 | 0.800 |
Why?
| Spheroids, Cellular | 1 | 2021 | 57 | 0.760 |
Why?
| Proto-Oncogene Proteins | 2 | 2018 | 646 | 0.750 |
Why?
| Aniline Compounds | 1 | 2020 | 71 | 0.740 |
Why?
| Nevus | 1 | 2020 | 31 | 0.730 |
Why?
| Tumor Suppressor Proteins | 2 | 2023 | 299 | 0.640 |
Why?
| Cell Survival | 7 | 2021 | 1075 | 0.610 |
Why?
| Apoptosis Regulatory Proteins | 3 | 2018 | 198 | 0.600 |
Why?
| Microtubule-Associated Proteins | 1 | 2018 | 187 | 0.600 |
Why?
| Hepatitis B Antibodies | 1 | 2016 | 10 | 0.580 |
Why?
| Immunity, Maternally-Acquired | 1 | 2016 | 26 | 0.580 |
Why?
| Hepatitis B virus | 1 | 2016 | 25 | 0.580 |
Why?
| Drug Synergism | 5 | 2017 | 346 | 0.580 |
Why?
| Drug Therapy, Combination | 2 | 2016 | 988 | 0.570 |
Why?
| Mitochondrial Proteins | 1 | 2018 | 231 | 0.570 |
Why?
| Genes, ras | 3 | 2008 | 99 | 0.560 |
Why?
| Hepatitis B Vaccines | 1 | 2016 | 48 | 0.560 |
Why?
| Lentigo | 1 | 2015 | 7 | 0.540 |
Why?
| Hyperthermia, Induced | 2 | 2007 | 67 | 0.530 |
Why?
| Xenograft Model Antitumor Assays | 5 | 2021 | 747 | 0.530 |
Why?
| Molecular Targeted Therapy | 2 | 2015 | 361 | 0.520 |
Why?
| Fenretinide | 1 | 2014 | 4 | 0.520 |
Why?
| Antibody Formation | 1 | 2016 | 285 | 0.510 |
Why?
| Piperazines | 5 | 2017 | 326 | 0.510 |
Why?
| Oligopeptides | 1 | 2016 | 255 | 0.510 |
Why?
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 1183 | 0.500 |
Why?
| Peptide Fragments | 1 | 2018 | 715 | 0.490 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 408 | 0.480 |
Why?
| Down-Regulation | 3 | 2012 | 654 | 0.440 |
Why?
| Cell Proliferation | 7 | 2017 | 2328 | 0.440 |
Why?
| L-Lactate Dehydrogenase | 1 | 2011 | 114 | 0.410 |
Why?
| Alkylating Agents | 1 | 2011 | 27 | 0.410 |
Why?
| Proto-Oncogene Proteins B-raf | 2 | 2016 | 204 | 0.410 |
Why?
| Dacarbazine | 1 | 2011 | 102 | 0.400 |
Why?
| Biological Assay | 1 | 2011 | 123 | 0.400 |
Why?
| Biomimetic Materials | 1 | 2011 | 69 | 0.380 |
Why?
| Mice, Nude | 5 | 2020 | 668 | 0.380 |
Why?
| Mice | 12 | 2021 | 15888 | 0.370 |
Why?
| Mutation | 8 | 2017 | 3493 | 0.360 |
Why?
| Humans | 40 | 2021 | 122796 | 0.350 |
Why?
| Indoles | 1 | 2011 | 318 | 0.350 |
Why?
| Ultraviolet Therapy | 2 | 2020 | 20 | 0.350 |
Why?
| Leupeptins | 1 | 2008 | 10 | 0.340 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2008 | 51 | 0.340 |
Why?
| Proteasome Inhibitors | 1 | 2008 | 46 | 0.340 |
Why?
| Skin Pigmentation | 2 | 2020 | 53 | 0.340 |
Why?
| Saccharomyces cerevisiae | 5 | 2011 | 507 | 0.340 |
Why?
| Vitiligo | 2 | 2020 | 77 | 0.320 |
Why?
| rho GTP-Binding Proteins | 2 | 2020 | 68 | 0.320 |
Why?
| Animals | 16 | 2021 | 34133 | 0.310 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 433 | 0.300 |
Why?
| Membrane Proteins | 2 | 2016 | 1093 | 0.300 |
Why?
| Neurofibromin 1 | 2 | 2017 | 22 | 0.300 |
Why?
| Caspases | 5 | 2017 | 275 | 0.300 |
Why?
| Cell Self Renewal | 2 | 2017 | 51 | 0.300 |
Why?
| Transfection | 5 | 2012 | 909 | 0.290 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2006 | 57 | 0.280 |
Why?
| Extracellular Matrix Proteins | 2 | 2006 | 133 | 0.280 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2006 | 131 | 0.270 |
Why?
| Endoplasmic Reticulum | 1 | 2007 | 250 | 0.270 |
Why?
| Exome | 2 | 2017 | 227 | 0.270 |
Why?
| Lovastatin | 1 | 2005 | 31 | 0.260 |
Why?
| Biomarkers, Tumor | 4 | 2017 | 1076 | 0.260 |
Why?
| Biotechnology | 1 | 2005 | 45 | 0.260 |
Why?
| Drug Resistance, Neoplasm | 4 | 2018 | 673 | 0.260 |
Why?
| Ankyrin Repeat | 1 | 2023 | 2 | 0.240 |
Why?
| Poly ADP Ribosylation | 1 | 2023 | 8 | 0.240 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 358 | 0.240 |
Why?
| Bcl-2-Like Protein 11 | 2 | 2017 | 39 | 0.240 |
Why?
| Equipment Failure Analysis | 1 | 2004 | 142 | 0.240 |
Why?
| Specimen Handling | 1 | 2004 | 169 | 0.220 |
Why?
| ras Proteins | 1 | 2003 | 142 | 0.220 |
Why?
| Biophysics | 1 | 2022 | 74 | 0.210 |
Why?
| Uveal Neoplasms | 1 | 2021 | 8 | 0.210 |
Why?
| Hot Temperature | 1 | 2004 | 345 | 0.210 |
Why?
| Hair Follicle | 2 | 2020 | 53 | 0.200 |
Why?
| Fungal Proteins | 2 | 1999 | 132 | 0.200 |
Why?
| Cell Cycle Proteins | 3 | 2000 | 576 | 0.190 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 410 | 0.190 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2003 | 537 | 0.190 |
Why?
| Neoplasm Recurrence, Local | 2 | 2016 | 903 | 0.190 |
Why?
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 25 | 0.190 |
Why?
| Neoplasm Invasiveness | 3 | 2013 | 472 | 0.190 |
Why?
| Adult Stem Cells | 1 | 2020 | 35 | 0.190 |
Why?
| beta Catenin | 2 | 2020 | 223 | 0.180 |
Why?
| CDC28 Protein Kinase, S cerevisiae | 1 | 1999 | 7 | 0.180 |
Why?
| Dynamins | 1 | 2018 | 31 | 0.170 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 1999 | 354 | 0.160 |
Why?
| Cancer Vaccines | 2 | 2011 | 141 | 0.160 |
Why?
| Cytokines | 1 | 2006 | 1928 | 0.160 |
Why?
| Cyclin-Dependent Kinases | 1 | 1999 | 114 | 0.160 |
Why?
| Melanoma, Experimental | 2 | 2011 | 116 | 0.160 |
Why?
| Ultraviolet Rays | 3 | 2008 | 413 | 0.160 |
Why?
| Zinc Finger Protein GLI1 | 1 | 2017 | 21 | 0.160 |
Why?
| Transforming Growth Factor beta | 1 | 2000 | 468 | 0.150 |
Why?
| Zebrafish Proteins | 1 | 2020 | 284 | 0.150 |
Why?
| Gene Knockout Techniques | 1 | 2017 | 107 | 0.150 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 61 | 0.150 |
Why?
| RNA Splicing Factors | 1 | 2017 | 51 | 0.150 |
Why?
| Disease Models, Animal | 3 | 2018 | 3799 | 0.150 |
Why?
| Mucous Membrane | 1 | 2017 | 120 | 0.140 |
Why?
| Female | 13 | 2020 | 63629 | 0.140 |
Why?
| Genes, erbB-1 | 1 | 2016 | 18 | 0.140 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2016 | 75 | 0.140 |
Why?
| Pyrroles | 1 | 2017 | 199 | 0.140 |
Why?
| Machine Learning | 1 | 2020 | 345 | 0.140 |
Why?
| Transcription, Genetic | 4 | 2017 | 1355 | 0.140 |
Why?
| Zebrafish | 1 | 2020 | 477 | 0.140 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2011 | 466 | 0.140 |
Why?
| Oncogene Proteins, Fusion | 1 | 2017 | 182 | 0.140 |
Why?
| Inflammasomes | 1 | 2017 | 123 | 0.130 |
Why?
| Signal Transduction | 4 | 2020 | 4902 | 0.130 |
Why?
| Phosphoproteins | 1 | 2017 | 332 | 0.130 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2020 | 852 | 0.130 |
Why?
| Retinoids | 1 | 2014 | 35 | 0.130 |
Why?
| Complementary Therapies | 1 | 2015 | 70 | 0.130 |
Why?
| Genetic Linkage | 1 | 2015 | 328 | 0.120 |
Why?
| Caspase 3 | 2 | 2005 | 246 | 0.120 |
Why?
| Cells, Cultured | 4 | 2020 | 4162 | 0.120 |
Why?
| Prognosis | 3 | 2020 | 3563 | 0.120 |
Why?
| Neoplasm Metastasis | 2 | 2013 | 563 | 0.120 |
Why?
| Aldehyde Dehydrogenase | 1 | 2014 | 135 | 0.120 |
Why?
| Genomic Instability | 1 | 2013 | 39 | 0.120 |
Why?
| Genes, Tumor Suppressor | 1 | 2013 | 79 | 0.120 |
Why?
| Smad1 Protein | 1 | 2012 | 20 | 0.110 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 60 | 0.110 |
Why?
| Stem Cells | 1 | 2017 | 576 | 0.110 |
Why?
| Neoplasm Proteins | 2 | 2007 | 415 | 0.110 |
Why?
| BRCA1 Protein | 1 | 2013 | 59 | 0.110 |
Why?
| Microarray Analysis | 1 | 2012 | 124 | 0.110 |
Why?
| Up-Regulation | 2 | 2006 | 891 | 0.110 |
Why?
| Tretinoin | 1 | 2013 | 119 | 0.110 |
Why?
| Alcohol Oxidoreductases | 1 | 2013 | 57 | 0.110 |
Why?
| Cellular Senescence | 1 | 2013 | 156 | 0.110 |
Why?
| Biomedical Research | 1 | 2018 | 630 | 0.110 |
Why?
| Disease Progression | 5 | 2020 | 2546 | 0.100 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 292 | 0.100 |
Why?
| Survival Analysis | 1 | 2015 | 1325 | 0.100 |
Why?
| Annexin A5 | 2 | 2013 | 25 | 0.100 |
Why?
| Vaccines, Synthetic | 1 | 2011 | 130 | 0.090 |
Why?
| Genetic Engineering | 1 | 2011 | 84 | 0.090 |
Why?
| Cell Death | 1 | 2011 | 345 | 0.090 |
Why?
| Time Factors | 3 | 2013 | 6682 | 0.090 |
Why?
| Phenotype | 2 | 2015 | 3070 | 0.090 |
Why?
| RNA Interference | 2 | 2009 | 473 | 0.090 |
Why?
| Aldose-Ketose Isomerases | 1 | 2009 | 7 | 0.090 |
Why?
| Treatment Outcome | 3 | 2020 | 9692 | 0.090 |
Why?
| rhoA GTP-Binding Protein | 1 | 2009 | 80 | 0.090 |
Why?
| Adenocarcinoma | 1 | 2016 | 837 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3662 | 0.090 |
Why?
| Precipitin Tests | 2 | 1999 | 99 | 0.090 |
Why?
| Protein Structure, Tertiary | 1 | 2011 | 832 | 0.080 |
Why?
| Methionine | 1 | 2009 | 147 | 0.080 |
Why?
| Anoikis | 1 | 2008 | 35 | 0.080 |
Why?
| Cell Line, Transformed | 1 | 2008 | 140 | 0.080 |
Why?
| Antioxidants | 2 | 2013 | 581 | 0.080 |
Why?
| Microphthalmia-Associated Transcription Factor | 1 | 2008 | 15 | 0.080 |
Why?
| Radiation-Protective Agents | 1 | 2008 | 28 | 0.080 |
Why?
| Heat-Shock Proteins | 1 | 2007 | 129 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 1 | 2011 | 1981 | 0.070 |
Why?
| Cysteine | 1 | 2008 | 187 | 0.070 |
Why?
| Young Adult | 3 | 2020 | 11094 | 0.070 |
Why?
| rhoC GTP-Binding Protein | 1 | 2006 | 5 | 0.070 |
Why?
| Enzyme Induction | 1 | 2006 | 94 | 0.070 |
Why?
| Molecular Chaperones | 1 | 2007 | 177 | 0.070 |
Why?
| Growth Substances | 1 | 2006 | 140 | 0.070 |
Why?
| Antigens, Neoplasm | 1 | 2007 | 228 | 0.070 |
Why?
| Models, Animal | 1 | 2008 | 373 | 0.070 |
Why?
| Ethidium | 1 | 2005 | 5 | 0.070 |
Why?
| Acridine Orange | 1 | 2005 | 6 | 0.070 |
Why?
| Caspase 7 | 1 | 2005 | 23 | 0.070 |
Why?
| Dimethylallyltranstransferase | 1 | 2005 | 2 | 0.070 |
Why?
| Polyisoprenyl Phosphates | 1 | 2005 | 2 | 0.070 |
Why?
| Risk Assessment | 1 | 2015 | 3213 | 0.070 |
Why?
| DNA-Binding Proteins | 1 | 2013 | 1384 | 0.070 |
Why?
| Pravastatin | 1 | 2005 | 33 | 0.070 |
Why?
| In Situ Nick-End Labeling | 1 | 2005 | 124 | 0.070 |
Why?
| Infant, Newborn | 1 | 2016 | 5430 | 0.070 |
Why?
| Jurkat Cells | 1 | 2005 | 139 | 0.070 |
Why?
| False Positive Reactions | 1 | 2005 | 118 | 0.070 |
Why?
| Sesquiterpenes | 1 | 2005 | 53 | 0.060 |
Why?
| Camptothecin | 1 | 2005 | 100 | 0.060 |
Why?
| Male | 5 | 2020 | 59639 | 0.060 |
Why?
| Prospective Studies | 1 | 2016 | 6704 | 0.060 |
Why?
| Adult | 5 | 2020 | 32385 | 0.060 |
Why?
| Necrosis | 1 | 2005 | 238 | 0.060 |
Why?
| Pregnancy | 1 | 2016 | 5854 | 0.060 |
Why?
| Transcriptional Activation | 1 | 2006 | 360 | 0.060 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 184 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2011 | 2977 | 0.060 |
Why?
| Feedback | 1 | 2004 | 155 | 0.060 |
Why?
| Cell Adhesion | 1 | 2005 | 454 | 0.060 |
Why?
| Molecular Sequence Data | 3 | 2009 | 2933 | 0.060 |
Why?
| Anticholesteremic Agents | 1 | 2005 | 136 | 0.060 |
Why?
| Fluorescent Dyes | 1 | 2005 | 319 | 0.060 |
Why?
| Gene Expression | 2 | 2017 | 1506 | 0.060 |
Why?
| Lung Neoplasms | 1 | 2016 | 2216 | 0.060 |
Why?
| Mitochondria | 1 | 2008 | 809 | 0.060 |
Why?
| Infant | 1 | 2016 | 8523 | 0.060 |
Why?
| Cell Hypoxia | 1 | 2003 | 229 | 0.050 |
Why?
| Inflammation | 1 | 2013 | 2598 | 0.050 |
Why?
| Equipment Design | 1 | 2004 | 533 | 0.050 |
Why?
| fas Receptor | 1 | 2002 | 95 | 0.050 |
Why?
| Proteomics | 2 | 2009 | 890 | 0.050 |
Why?
| Tumor Cells, Cultured | 2 | 2002 | 904 | 0.050 |
Why?
| Cell Division | 2 | 2002 | 788 | 0.050 |
Why?
| Interleukin-1 | 1 | 2006 | 987 | 0.050 |
Why?
| Substrate Specificity | 2 | 1999 | 375 | 0.050 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2023 | 241 | 0.050 |
Why?
| Chromatin | 1 | 2005 | 450 | 0.050 |
Why?
| Temperature | 1 | 2004 | 631 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 836 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1181 | 0.050 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2023 | 513 | 0.050 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2020 | 50 | 0.050 |
Why?
| Amino Acid Sequence | 2 | 2009 | 2123 | 0.050 |
Why?
| MART-1 Antigen | 2 | 2011 | 9 | 0.050 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 432 | 0.040 |
Why?
| Carcinoma, Squamous Cell | 1 | 2005 | 622 | 0.040 |
Why?
| Chromatography, Ion Exchange | 1 | 1999 | 53 | 0.040 |
Why?
| Chromatography, Affinity | 1 | 1999 | 87 | 0.040 |
Why?
| Cytotoxicity, Immunologic | 2 | 2011 | 204 | 0.040 |
Why?
| Keratinocytes | 1 | 2020 | 238 | 0.040 |
Why?
| Hybrid Cells | 1 | 1998 | 46 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 1998 | 62 | 0.040 |
Why?
| Cyclins | 1 | 1999 | 82 | 0.040 |
Why?
| RNA, Messenger | 2 | 2003 | 2720 | 0.040 |
Why?
| Cell Movement | 1 | 2023 | 929 | 0.040 |
Why?
| Immunoblotting | 1 | 1999 | 318 | 0.040 |
Why?
| Molecular Weight | 1 | 1998 | 346 | 0.040 |
Why?
| Pigmentation | 1 | 2018 | 61 | 0.040 |
Why?
| Laser Capture Microdissection | 1 | 2017 | 27 | 0.040 |
Why?
| NLR Proteins | 1 | 2017 | 7 | 0.040 |
Why?
| Protein Kinases | 1 | 1999 | 325 | 0.040 |
Why?
| Middle Aged | 4 | 2020 | 28563 | 0.040 |
Why?
| Neoplasm Transplantation | 1 | 2017 | 248 | 0.040 |
Why?
| Protein Isoforms | 1 | 2017 | 347 | 0.040 |
Why?
| Cell Cycle | 1 | 1999 | 584 | 0.040 |
Why?
| Tumor Burden | 1 | 2017 | 277 | 0.030 |
Why?
| Survival Rate | 1 | 2020 | 1810 | 0.030 |
Why?
| Phosphorylation | 1 | 2000 | 1733 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2016 | 167 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 420 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2016 | 390 | 0.030 |
Why?
| Aged | 3 | 2020 | 20495 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 459 | 0.030 |
Why?
| Monophenol Monooxygenase | 1 | 2013 | 12 | 0.030 |
Why?
| Microscopy, Phase-Contrast | 1 | 2013 | 19 | 0.030 |
Why?
| Spectrophotometry | 1 | 2013 | 52 | 0.030 |
Why?
| Melanins | 1 | 2013 | 23 | 0.030 |
Why?
| Catalase | 1 | 2013 | 125 | 0.030 |
Why?
| Administration, Topical | 1 | 2013 | 154 | 0.030 |
Why?
| Cell Differentiation | 1 | 2020 | 1805 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2013 | 155 | 0.030 |
Why?
| Precision Medicine | 1 | 2016 | 371 | 0.030 |
Why?
| Computational Biology | 1 | 2016 | 601 | 0.030 |
Why?
| Superoxide Dismutase | 1 | 2013 | 345 | 0.020 |
Why?
| DNA Repair | 1 | 2013 | 203 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2000 | 2491 | 0.020 |
Why?
| DNA Damage | 1 | 2013 | 368 | 0.020 |
Why?
| Mice, Inbred C57BL | 2 | 2011 | 5020 | 0.020 |
Why?
| Case-Control Studies | 1 | 2017 | 3296 | 0.020 |
Why?
| S-Adenosylmethionine | 1 | 2009 | 54 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2009 | 194 | 0.020 |
Why?
| Histones | 1 | 2013 | 562 | 0.020 |
Why?
| Mice, Hairless | 1 | 2008 | 74 | 0.020 |
Why?
| Molecular Structure | 1 | 2009 | 463 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2017 | 4768 | 0.020 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2007 | 49 | 0.020 |
Why?
| 3' Untranslated Regions | 1 | 2008 | 147 | 0.020 |
Why?
| Enzyme Activation | 1 | 2009 | 864 | 0.020 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 153 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2008 | 518 | 0.020 |
Why?
| Genome, Human | 1 | 2008 | 392 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6845 | 0.020 |
Why?
| Spleen | 1 | 2007 | 543 | 0.020 |
Why?
| Alleles | 1 | 2008 | 852 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2007 | 884 | 0.020 |
Why?
| Cathepsin D | 1 | 2003 | 13 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2007 | 1318 | 0.020 |
Why?
| Interferon-gamma | 1 | 2007 | 747 | 0.010 |
Why?
| Base Sequence | 1 | 2008 | 2186 | 0.010 |
Why?
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 21 | 0.010 |
Why?
| Fas Ligand Protein | 1 | 2002 | 60 | 0.010 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2007 | 715 | 0.010 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 373 | 0.010 |
Why?
| Adolescent | 1 | 2020 | 18948 | 0.010 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2007 | 1003 | 0.010 |
Why?
| Protein Processing, Post-Translational | 1 | 2003 | 421 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2008 | 1625 | 0.010 |
Why?
| Child | 1 | 2020 | 19561 | 0.010 |
Why?
| Receptors, Cell Surface | 1 | 2002 | 368 | 0.010 |
Why?
| Mass Spectrometry | 1 | 2003 | 686 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 462 | 0.010 |
Why?
| Apc6 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 1999 | 1 | 0.010 |
Why?
| Vaccination | 1 | 2007 | 1241 | 0.010 |
Why?
| Nuclear Proteins | 1 | 2003 | 618 | 0.010 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 1999 | 103 | 0.010 |
Why?
| Carrier Proteins | 1 | 2002 | 740 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 1999 | 661 | 0.010 |
Why?
|
|
Shellman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|